Our investigators and physicians realize that many challenges remain in the treatment of childhood cancers and genetic tumor predisposition syndromes but we are committed to improving outcomes for children and young adults with these diseases through cutting-edge basic and clinical research. Patients with cancer, neurofibromatosis type 1 (NF1), NF2 or other diseases under study who are enrolled on Branch clinical trials may receive therapy at the NIH Clinical Center.
Learn more about participating in or partnering with us to enroll a patient in our clinical trials at the NIH Clinical Center in Bethesda, MD. Explore whether one may be right for you, a patient, or a loved one.
